EUROAPI Competitors and Similar CompaniesClear all
EUROAPI's competitors and similar companies include GSK, Shanghai Medicilon, Hubei Guangji Pharmaceutical and Wuhan Xianlu Pharmaceutical Technology.
 GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. |  Shanghai Medicilon Shanghai Medicilon (美迪西生物医药) is a contract research organization (CRO) that provides biopharmaceutical preclinical research and development solutions. |  Hubei Guangji Pharmaceutical Hubei Guangji Pharmaceutical (湖北广济药业股份有限公司) is a distributor of drugs and pharmaceutical raw materials. |  Wuhan Xianlu Pharmaceutical Technology Wuhan Xianlu Pharmaceutical Technology (武汉先路医药科技股份有限公) is a producer and supplier of pharmaceutical products. | ||
Founding Date | Founding Date 2020 | Founding Date 2000 | Founding Date 2004 | Founding Date 1969 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Paris, FR HQ | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more | Locations Shanghai, CN HQ | Locations Huanggang, CN HQ | Locations Wuhan, CN HQ |
Employees | Employees 3,187 | Employees 68,629 | Employees 2,600 | Employees 1,39825% decrease | Employees N/A |
Valuation ($) | Valuation ($) 368.2 m | Valuation ($) 862.5 m | Valuation ($) 664.4 m | Valuation ($) 278.2 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) €848.2m (FY, 2025) | Revenue (est.) £32.7b (FY, 2025) | Revenue (est.) ¥1.2b (FY, 2025) | Revenue (est.) ¥619.5m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods €645.6m (FY, 2025) | Cost of goods £5.6b (FY, 2025) | Cost of goods ¥961.2m (FY, 2025) | Cost of goods ¥519.1m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit €208.8m (FY, 2025) | Gross profit £28.5b (FY, 2025) | Gross profit ¥200.3m (FY, 2025) | Gross profit ¥104.1m (FY, 2024) | Gross profit N/A |
Net income | Net income (€211.1m) (FY, 2025) | Net income £6.3b (FY, 2025) | Net income (¥167.8m) (FY, 2025) | Net income (¥315.1m) (FY, 2024) | Net income N/A |
Operating ⚠ | |||||
Countries | Countries 80 (Nov, 2022) | Countries 92 (FY, 2021) | Countries N/A | Countries N/A | Countries N/A |
For sources of this data, please see the company profile
View Company Profiles
GSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View companyShanghai Medicilon
HQ
Shanghai, CN
Employees
2,600
Shanghai Medicilon (美迪西生物医药) is a contract research organization (CRO) that provides biopharmaceutical preclinical research and development solutions.
View companyHubei Guangji Pharmaceutical
HQ
Huanggang, CN
Employees
1,398↓ 25% decrease
Hubei Guangji Pharmaceutical (湖北广济药业股份有限公司) is a distributor of drugs and pharmaceutical raw materials.
View companyWuhan Xianlu Pharmaceutical Technology
HQ
Wuhan, CN
Wuhan Xianlu Pharmaceutical Technology (武汉先路医药科技股份有限公) is a producer and supplier of pharmaceutical products.
View company